Sign inJoin waitlistJoin the waitlist

AJ

Ann Jakubowski

Clinical Director, Adult Bone Marrow Transplantation Outpatient Unit · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Adult Bone Marrow Transplantation Outpatient Unit · New York Presbyterian Hospital
Present

Montefiore and Albert Einstein Medical Centers
1987–1988
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1984–1987
Mount Sinai Hospital
1981–1984
Wesleyan University
University of Connecticut School of Medicine
1977–1981

Research

Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
New England Journal of Medicine · 1991 · 1,289 citations
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
New England Journal of Medicine · 1988 · 967 citations
Developing a cancer-specific geriatric assessment: a feasibility study
Cancer · 2005 · 502 citations

SG
Sergio Giralt
101 papers
MP
Miguel-Angel Perales
96 papers
EP
Esperanza Papadopoulos
93 papers
RT
Roni Tamari
55 papers
HC
Hugo Castro-Malaspina
54 papers
Richard O’Reilly
49 papers
DP
Doris Ponce
43 papers
Juliet Barker
43 papers
BS
Brian Shaffer
41 papers
Christina Cho
37 papers · 10 as a fellow
Craig Sauter
37 papers
PD
Parastoo Dahi
37 papers

Clinical trials

Cord Blood Transplant in Adults With Blood Cancers
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2028
GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
Principal investigator · Terminated
Memorial Sloan Kettering Cancer Center
2015–2017
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2007–2015
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2001–2011